Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin added to intermittent preventive malaria treatment in pregnancy to reduce low birth weight
PACTR201808177464681Phase 4Recruiting
- Sponsor
- Clinical Research Unit of Nanoro
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Placental Malaria (PM) and low birth weight (LBW) comparing Azithromycin + sulfadoxine-pyrimethamine with Sulfadoxine-pyrimethamine control (2 arms). Primary endpoint: Proportion of low birth weight. Started Oct 2018; status: recruiting.
02
Drugs
azithromycinsulfadoxine + pyrimethamine
03
Conditions
Placental Malaria (PM)low birth weight (LBW)
Beyond the preview
Go deeper on PACTR201808177464681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201808177464681.